Genturi Competitors and Similar CompaniesClear all
Genturi's competitors and similar companies include ReCode Therapeutics, Nanobiosym and 20Med Therapeutics.
 ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  Nanobiosym Nanobiosym (NBS) is a company that focuses on the commercialization of its proprietary technology platform, that can detect genetic fingerprints from biological organisms, providing people with diagnostic information about their health. |  20Med Therapeutics 20Med Therapeutics is a biotechnology company applying nanotechnology for the development of RNA therapeutics. | ||
Founding Date | Founding Date 2018 | Founding Date 2015 | Founding Date 2004 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Woburn, US HQ | Locations Menlo Park, US HQ | Locations Cambridge, US HQ | Locations Leiden, NL HQ Enschede, NL |
Employees | Employees 433% increase | Employees 1062% decrease | Employees 9 | Employees 11 |
For sources of this data, please see the company profile
View Company Profiles
ReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View companyNanobiosym
HQ
Cambridge, US
Employees
9
Nanobiosym (NBS) is a company that focuses on the commercialization of its proprietary technology platform, that can detect genetic fingerprints from biological organisms, providing people with diagnostic information about their health.
View company20Med Therapeutics
HQ
Leiden, NL
Employees
11
20Med Therapeutics is a biotechnology company applying nanotechnology for the development of RNA therapeutics.
View company